Monobind is a privately held company founded in 1978 by Dr. Frederick Jerome. Since that time, Dr. Jerome has served as Monobind's president overseeing every aspect of the company's development, from building our initial radio-immunoassays, designing our current robust ELISA product line, to establishing our ever-growing range of custom manufactured biomaterials. For further details see Monobind's Fact Sheet

If you would like to inquire about investment opportunities, you may contact us at investors@monobind.com.